WASHINGTON (Legal Newsline) – The Federal Trade Commission is suing several major pharmaceutical companies, saying they illegally blocked consumer access to lower-cost versions of the drug AndroGel.
(Reuters) - Any way you look at it, AbbVie (ABBV.N), opens new tab predecessor Abbott Laboratories (ABT.N), opens new tab made a bad decision when it sued generic drug maker Perrigo (PRGO.N), opens ...
WASHINGTON, Feb 2 (Reuters) - Federal and state regulators have challenged agreements made by Solvay SA with generic drug companies Watson Pharmaceuticals Inc , Par Pharmaceuticals and Paddock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback